HOUSTON- Novum Pharmaceutical Research Services, a contract research organization serving the pharmaceutical industry in Phase I-Phase IV clinical trials and related services, announced that construction is underway on its new, 55,000 square foot, early-stage clinical facility in Houston. According to area reports, the facility will come online this summer.

The Good Clinical Practice-compliant facility is going north in the Westchase submarket, near Novum's current clinics at 3320 Walnut Bend. The new facility will have seven research units that are designed to make the most efficient use of its 225 beds. Additionally, a 12-bed intensive monitoring unit will allow for early phase research studies requiring continuous cardiac and other specialized safety monitoring. The floor plan and layout are designed to provide a high degree of flexibility in space planning to handle multiple types of study designs.

"This exciting new facility reflects Novum's continued growth and our deep commitment to our clients' needs," says Christopher H. Chamberlain, Novum's CEO in a prepared statement. "Like our other research facilities, it will provide a safe, convenient, and pleasant environment for our study participants," he added.

"While our employees and study participants truly make the difference at Novum, bringing this state-of-the-art facility online will raise the bar for Novum and the industry," adds Darin Brimhall, Novum's vice president of clinic operations in a prepared statement. A call to Brimhall for more information was not returned by deadline.

Instant Insights /

Novum to Open 55,000-SF Facility

Related Stories

Recommended For You